(Reuters) - U.S. pharmaceutical research services provider Parexel International Corp (PRXL.O) said on Tuesday it would be taken private by Pamplona Capital Management LLP in a $4.5 billion deal.

Strategic collaboration with a leading global CRO supports disciplined trial execution and operational efficiency, advancing Faron's mission to provide treatment for patients with HR-MDS TURKU, FI / ...

The collaboration between Parexel and Partex is designed to leverage artificial intelligence-powered solutions to accelerate drug discovery and development. Parexel, a clinical research organization ...

BOSTON, Aug. 2, 2012 /PRNewswire/ -- PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global consultancy serving the biopharmaceutical and medical device ...

EQT Private Equity and the private equity business of Goldman Sachs Asset Management announced the acquisition agreement Friday. The deal comes four years after Parexel was purchased by Pamplona ...

In a recent press release from Microsoft Corp. and PAREXEL International Corp., a leading global biopharmaceutical services organization, on Tuesday announced a technology development alliance aimed ...

BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced it has been ranked #1 among global Clinical Research Organizations ...

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and ...

BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation, a leading global biopharmaceutical services provider, today introduced its enhanced Global Data Operations (GDO) solution, with augmented ...

IFS AB acquired Assyst, formerly Axios Assyst, in March 2021 with the goal of enabling IT and enterprise service management, as well as IT operations management. The platform allows businesses to ...

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the fourth quarter and Fiscal Year 2014, which ended on June 30, 2014. In commenting on the results of the quarter ...